Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

CB Therapeutics Introduces Sustainable Retinol Production

By: Newsfile

Carlsbad, California--(Newsfile Corp. - May 9, 2024) - CB Therapeutics, a premier biotechnology firm specializing in precision fermentation, proudly unveils its latest breakthrough: Retinol, the quintessential solution for achieving radiant and youthful skin. Long revered by skincare experts for its transformative properties, Retinol, a derivative of vitamin A, now enters a new era of production thanks to CB Therapeutics' cutting-edge precision fermentation and synthetic biology techniques.

This groundbreaking process revolutionizes Retinol production, enabling rapid, clean, and eco-friendly synthesis of both the compound itself and its derivatives. Unlike conventional methods, precision fermentation minimizes resource consumption and significantly reduces the carbon footprint associated with production. Moreover, it facilitates the seamless development and production of novel Retinol variants with enhanced properties, promising a new frontier in skincare innovation.

Sher Butt, CEO of CB Therapeutics, expressed enthusiasm about this development, highlighting the global demand for eco-friendly alternatives in the skincare industry. "We are thrilled to be at the forefront of the clean wellness and beauty revolution," remarked Butt. "With only a select few biotech companies achieving this feat, we take pride in our contribution to advancing sustainable practices in the industry."

Dr. Jacob Vogan, CSO at CB Therapeutics said, "We are extending an invitation to companies in the clean beauty and wellness space for collaboration, envisioning the creation of unparalleled products in the sector."

About CB Therapeutics:

CB Therapeutics' expertise in synthetic genomics and bio-engineering has significantly advanced its proprietary production platform of microorganisms, enzymes, and production processes. After more than nine years of research and development, the CB Therapeutics team can produce a broad range of phytochemicals faster, utilizing fewer resources, at greater yields, and with more purity, consistency, and efficiency than competing platforms. CB Therapeutics operates from their new 16,000 sq. ft. facility in southern California.

Contact Information:

Partnership Inquiries:
Sher Ali Butt
CEO, CB Therapeutics
Email: sher@cbthera.com

Follow CB Therapeutics on Twitter: @CBTherapeutics
Follow CB Therapeutics on Instagram: https://www.instagram.com/cb_thera/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/208457

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.